OPTOLANE Exploits the ‘Semiconductor-based PCR’ for POC·Liquid Biopsy
입력 2018-09-11 09:41 수정 2019-02-02 14:23
by Euna Lee
OPTOLANE, the in vitro diagnostics company, is now developing the ‘Semiconductor-based in vitro Diagnostic Platform’ by using the fluorescence image sensor integrated with thermal control system.
OPTOLANE is heading for exploitation of the platform in the field of the early diagnostics of diseases, and the studies on cancers through ‘point-of-care (POC)’ and ‘liquid biopsy’. OPTOLANE is developing portable real-time polymerase chain reaction (PCR) and digital PCR products through an implementation of the CMOS bio-sensor technology born in SiliconFile Technologies, Inc. back in 2007.
OPTOLANE is also developing the ‘All-In-One PCR system’ as well, where extracts the DNA/RNA from a tiny amount of specimen, runs Real-Time PCR, and analyzes PCR results in the series of automatic process.
Do Young Lee, the CEO and President of OPTOLANE, founded SiliconFile Technologies, Inc., a fabless IC design company that specialized in first-generation CMOS image sensors, in 2002, and his career since then has been as a CTO, and a CEO later. When he sold SiliconFile Technologies, Inc. to SK Hynix Inc. in 2014, he also bought the equipment for the Bio R&D business and corresponding intellectual properties to OPTOLANE.
1. Semiconductor-based Real-time PCR… “Developing POC Molecular Diagnostics for Mosquito-borne Viruses etc.”...